BLAUVELT, A.; LANGLEY, R. G.; PERIS, K.; SILVESTRE, J. F.; KATOH, N.; TAUBER, M.; PINTER, A.; AMEEN, M.; GOODERHAM, M.; ØLAND, C. B.; TINDBERG, A.-M.; GJERUM, L.; REICH, K. Continuous Tralokinumab Treatment over 4 Years in Adults with Moderate-to-Severe Atopic Dermatitis Provides Long-Term Disease Control. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 2, p. s376, 2024. DOI: 10.25251/skin.8.supp.376. Disponível em: https://jofskin.org/index.php/skin/article/view/2679. Acesso em: 22 jul. 2024.